
RegulatoryNov 17, 2026, 04:34 PM
Ping An Biomedical Regains Nasdaq Minimum Bid Price Compliance
AI Summary
Ping An Biomedical Co., Ltd. has regained compliance with Nasdaq's minimum bid price requirement. The company received formal notification from Nasdaq on November 16, 2026, after its ordinary shares closed at $1.00 or greater for 10 consecutive business days from November 2 to November 13, 2026. This resolves the deficiency previously identified on November 24, 2025, and the matter is now closed. The company had previously been granted an extension until November 23, 2026, to regain compliance.
Key Highlights
- Ping An Biomedical Co., Ltd. has regained compliance with Nasdaq's minimum bid price requirement.
- The company's ordinary shares closed at $1.00 or greater for 10 consecutive business days from November 2 to November 13, 2026.
- Nasdaq provided formal notification of regained compliance on November 16, 2026.
- The previous bid price deficiency, identified on November 24, 2025, is now considered closed by Nasdaq.
- The company was previously granted an extension until November 23, 2026, to regain compliance.
Price Impact
More from PASW